Week 277 Review - Magic formula shares shine

In a week when OPTI:Optibiotix stays flat, the rest of the portfolio have a chance to influence performance. This week the ISA rather let me down, but the magic formula shares were amazing in the SIPP. Combined portfolio value is up by £766 and the deficit between cost and value reduced to £25,319 with total value £99,368. This is just about as flat a week as I've had for a long time when the difference is less than £1,000, as normally a 1p change in OPTI is enough to beat that.

There were no shares losing 5% or more this week. A rare and happy occurrence.

APAX:Apax Global Alpha was the first of the magic formula shares to do well, with a 5% climb. I think this is just down to a gradual recovery after I bought them at a post-Covid bargain. They are now up by 24% and making £237 potential profit as well as having paid £33 in dividends.

BLU:Blue Star Capital also climbed 5% possibly due to the massive increase in Stellar Lumens cryptocurrency. It probably increased the value of Satoshipay quite a bit. I'm still 77% down on these though, and I don't hold out enormous hopes for my £520 toe-dip stake.

CAML:Central Asia Metals have been on a great run for a while now, and climbed another 5% this week despite being ex-dividend. It appears a large institutional holder has been selling for some time, which could explain the insane cheapness of the shares. I don't care as it allowed me to buy around 2,500 shares below 160p when they have now hit 200p since the selling stopped, and my holding is up 8% and making £904 potential profit. I think fair value is 300p which will give me £6,681 potential profit, but while this management team are in charge I'll be keeping them for the dividend.

FXPO:Ferrexpo are another magic formula share and rose 6% to go 13% up and making £135 potential profit along with the £65 I've had in dividends. No particular reason for the climb other than recovery from post-Covid lows.

ITV:ITV are my most recent and most successful magic formula share, climbing 6% this week to go 34% up and making £341 potential profit. Just a bit annoying that I selected them for their historically high dividends, and that hasn't been reinstated yet.

IES:Invinity Energy have started giving me a tiny ray of hope that one of my most misguided investments might work out. When RED:RedT Energy as good as went bust, I thought my £1,092 investment was doomed, but the new company seem to have much more success at winning contracts, so they are up 6% this week and only 64% down altogether. Hope is re-kindled.

Share of the Week is IQE:IQE, climbing 7% after a long period in the doldrums. I think there's enough positivity to keep this going now, as they may very well be about to return to profitability. My ISA holding is only 14% down, and given I only bought these as a quick win while holding for a SBTX:SkinBioTherapeutics drop, I'll be selling them as fast as I can then they get in profit, as I haven't lost my ambition to spend the proceeds on more SBTX.

Pretty flat for a few weeks now.

Just above the trend line which ought to steepen as the March dip moves towards the left of the chart, so it may get increasingly difficult to stay above the line.

The ISA and share accounts look like this

			Weekly Change
Cash	£9.70		+£0
Portfolio cost	£62,990.04		+£0
Portfolio sell value (bid price-commission)	£48,432.48	(-23.1%)	-£14.29
Potential profits	£3,972.05		-£100.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£147.03	(2.8%)	-£9.19
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£345.94	(6.6%)	-£1.26
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	9.9%		-0.1%
Compound performance	53%		+0%

About as flat a week as you could get. The drop of 0.1p for JLP:Jubilee Metals caused potential profits to drop by £100, but increases elsewhere meant the overall value only dropped by £14. Long term performance as a percentage of injection amount dropped below the target 10%.

Flat.

Above the trend line = good.

The SIPP looks like this after week 261

			Weekly Change
Cash	£138.65		+£0
Portfolio cost	£58,959.20		+£0
Portfolio sell value (bid price - commission)	£48,848.88	(-17.1%)	+£750.99
Potential profits	£1,847.63		+£797.09
Yr 6 Dividends	£0		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£0		+£0
Yr 6 Average monthly cash profit	£0	(0%)	+£0
Total Dividends	£2,067.08		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£280.68	(5.7%)	-£1.08
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.9%		+0%
Compound performance	45%		+0%

A nice increase in potential profits of £797 thanks to the magic formula shares, but a few losses deepened to result in the overall value not going up by quite as much. Still a pretty great week for the SIPP given OPTI:Optibiotix didn't change. This is week 1 of year 6, so nothing much happening there.

A noticeable tick upwards recovering last week's small loss.

It feels like we're not that far from this account going back into profit. If OPTI:Optibiotix can get back in the black we should be there.

The trading account looks like this after week 227

			Weekly Change
Cash	£236.18		+£0
Portfolio cost	£2,354.11		+£0
Portfolio sell value (bid price - commission)	£1,702.31	(-27.7%)	+£30.12
Potential profits	£0		+£0
Year 5 Dividends	£0		+£0
Year 5 Profit	£370.12		+£0
Yr 5 Average monthly cash profit	£84.41	(43.0%)	-£4.69
Dividends	£47.92		+£0
Profit from sales	£656.49		+£0
Average monthly cash profit	£13.45	(6.9%)	-£0.06
(Sold stocks profit + Dividends - Fees  / Months)

A small tick upwards despite SBTX:SkinBioTherapeutics falling 3%. Both CAML:Central Asia Metals and IQE:IQE are looking promising for a potential sell in the new year.

Absolutely brilliant that this account is reasonably well above the injection line, so at least if I abandon the whole thing, I'll have made a small profit.

Rising more steeply than the trend line - can it keep going?

Here's my wish list

1. TLOU:Tlou Energy announce de-watering has resumed. No news and the price dropped 4% this week. Surely it has to be coming soon?
   
2. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. No news yet, but the drop of only 0.1p this week shows that even with profit taking, to buys are preventing a crash back to the 6p area some are predicting. I'm just keeping everything crossed one of these two news stories drops this week to keep the momentum up.
   
3. OPTI:Optibiotix to get within 10% of profit. Well, they didn't go any lower this week. Things have been strangely quiet. In the past there's been a habit of some big surprise appearing after a quiet persiod, so I will keep hoping.
4. CMCL:Caledonia Mining reverses the down trend and gets back into profit. Nope. Down another 4% this week to go a worrying 25% down. That's pretty dreadful, but at such a low P/E ratio all it needs is confirmation production is up and we should see a swift reversal. Work to increase capacity will come on-line soon, so I still have high hopes.
5.  SBTX:SkinBioTherapeutics gets back into profit. Nope - the reverse as we had a 3% drop.
   

My pension transfer request for £2,000 has been acted on by Legal & General, as my account has dropped by that amount. It usually takes about 3 days to get into my account, so we may have a quick turnaround this time. 

Here are my plans from last week:

If OPTI:Optibiotix less than 60p then buy - else
If SBTX:SkinBioTherapeutics less than 17p then buy - else
If DDDD:4D Pharma less than 100p then buy - else
Buy PLUS:Plus500 and PSN:Persimmon

At the moment OPTI:Optibiotix is still below 60p, so I am destined to increase my holding there if it stays at this level.  SBTX:SkinBioTherapeutics is also below 17p at 16.75p, and DDDD:4D Pharma is 99.4p so again still in the price range. Looks like the new magic formula shares won't get a look-in.

Week 276 Review - Pretty good week despite the drop

This week wasn't bad at all. A 3p drop in OPTI:Optibiotix following more good news was frustrating but seems to be a regular occurrence. That should have caused my portfolio to drop by £3,300 but it only fell by £1,910 showing just how well the other shares did. The deficit between cost and value rose to £26,086 and sadly the total portfolio value dropped back below £100K to £98,601.

Biggest losers were CMCL:Caledonia Mining and OPTI:Optibiotix, both of which dropped 5% and both of which don't seem to have any reason for the drop. They are both down by around 20% and I am terribly, terribly vexed.

Fortunately there were lots of big gains this week, with IES:Invinity Energy climbing 5% after announcing some new contracts and SAE:Simec Atlantis Energy also rising 5% but for no obvious reason.

PAY:Paypoint climbed 9% to go back in profit and above where they were when news broke of the competition law issues. They are 5% up now.

SBTX:SkinBioTherapeutics have been sliding since I bought them but did a reversal to climb 13% this week. They only need another 5% to be back in profit.

JLP:Jubilee Metals have been runner up for Share of the Week for the last 2 weeks despite making massive gains, but this week made another 18% and win the prize. They are now a wonderful 94% up on my purchase price and making £4,072 potential profit.

Just a tiny tick downwards.

It looks less tiny on here, but still just above the trend line.

The ISA and share accounts look like this

			Weekly Change
Cash	£9.70		+£0
Portfolio cost	£62,990.04		+£0
Portfolio sell value (bid price-commission)	£48,446.77	(-23.1%)	-£1,350.95
Potential profits	£4,072.05		+£800.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£156.22	(3.0%)	-£10.41
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£347.20	(6.6%)	-£1.26
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.0%		+0%
Compound performance	53%		+0%

An annoying drop, but countered by a brilliant increase in potential profits of £800 as JLP:Jubilee Metals continues to soar. The rise has been on no news, so hopefully can only be boosted when expected news comes through on fine chrome processing starting again and the permission to process PGM tailings at DCM. There have been mutterings of current fair value being 9.5p, so there could be another 1p rise to come.

Nothing to worry about.

Still above the trend line.

The SIPP looks like this after week 260 and the end of year 5.

			Weekly Change
Cash	£138.65		+£0
Portfolio cost	£58,959.20		+£0
Portfolio sell value (bid price - commission)	£48,097.89	(-18.4%)	-£631.56
Potential profits	£1,050.54		+£319.01
Yr 5 Dividends	£167.84		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£2,910.34		+£0
Yr 5 Average monthly cash profit	£241.72	(4.9%)	-£4.74
Total Dividends	£2,067.08		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£281.76	(5.7%)	-£1.09
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.9%		+0%
Compound performance	45%		+0%

A much smaller drop in value as so many shares did well this week, and there was much rejoicing when CAML:Central Asia Metals went back in profit despite having dividend ex-date for a 6p per share dividend worth £346. That will be a nice Christmas present.

Potential profits increased by £319 and £268 of that was CAML:Central Asia Metals. PAY:Paypoint also went back into profit, so there are now 6 shares in profit, with SBTX:SkinBioTherapeutics only down by 5% and the only magic formula share making a loss is CMCL:Caledonia Mining but I'm pretty certain that will turn around soon.

This was the last week of year 5 and my performance over the year in sales and dividends was an average of £241 a month. That's 4.9% of the current portfolio value, or more importantly 7.6% of the injection amount. It's below my long term average of £281 per month (8.9% of injection value), but still way better than any other type of savings account.

The profits were £905 from JLP:Jubilee Metals, £690 from SBTX:SkinBioTherapeutics and £2,258 from DDDD:4D Pharma. I also took a loss of £553 selling no-hopers N4P:N4 Pharma and £390 selling MMX:Minds + Machines when red flags started waving furiously. Dividends were negligible but contributed £167. That will be significantly boosted this year as CAML:Central Asia Metals re-instate the dividend and the magic formula shares get a full year paying them.

You can barely see the tick downwards

Just about above the trend line, but at least that's pointing upwards now.

The trading account looks like this after week 226

			Weekly Change
Cash	£236.18		+£0
Portfolio cost	£2,354.11		+£0
Portfolio sell value (bid price - commission)	£1,672.19	(-29.0%)	+£71.58
Potential profits	£0		+£0
Year 5 Dividends	£0		+£0
Year 5 Profit	£370.12		+£0
Yr 5 Average monthly cash profit	£89.10	(45.4%)	-£5.24
Dividends	£47.92		+£0
Profit from sales	£656.49		+£0
Average monthly cash profit	£13.51	(6.9%)	-£0.06
(Sold stocks profit + Dividends - Fees  / Months)

A great week, especially thanks to the recovery in SBTX:SkinBioTherapeutics. These are only 5% down now, so I may get to reap another £100 soon. CAML:Central Asia Metals are the next closest to profit, although still 25% down. I forgot until just now that I'll get £12 dividend from these next month. Every little helps! This account is making me quite happy at the moment, as if I don't sell anything at all for the next 7 months, I'll still have made 15% this year. My long term performance will also be good at 6% if I don't sell anything else. Hopefully I'll get to sell quite a few things and these figures will be blown out of the water.

Well above the injection line and heading firmly towards the cost line.

The trend line is getting gradually steeper as the slow recovery continues.

Here's my wish list

1. TLOU:Tlou Energy announce de-watering has resumed. Still no news, and there was a 2% pull back this week, but we remain hopeful.
2. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. Three weeks of massive gains and still this news hasn't dropped. At some point the profit taking will kick in, in fact it already has but the buying pressure is too great to prevent the upward momentum..
3. OPTI:Optibiotix to get within 10% of profit. Not really helped by a 5% drop this week. I'm keeping the wish though, as although 20% down, that could be made back very quickly.
   

I'm running a little short on wishes. I guess the key one is CMCL:Caledonia Mining reverses the down trend and gets back into profit so all my magic formula shares will be in profit. Another new one will be SBTX:SkinBioTherapeutics gets back into profit, and that I can sell the ones in the trading account.

I was looking at my shares account, as it's where the trading account shares live. It also houses 3,965 OPTI:Optibiotix shares which I bought hoping to make a quick return to pay for a holiday to Antarctica. That's all gone horribly wrong, what with OPTI:Optibiotix being down after 5 years and Covid scuppering any chance of going on holiday anyway. Plus Antarctic trips cost about £16K so I'd need a lot more shares than 3,965.

I was thinking I should give up and move them into my ISA, but then I had a thought. These have been in an entirely separate account for years - and it's the account where I keep my trading shares. Why the hell haven't I been using this pot for trading?! 

And so the decision has been made. As soon as these get into profit I'm going to start trading them, and push any profits into my SIPP so I can get the tax rebate and buy more OPTI. I'm kicking myself for not thinking of this 2 years ago!

Meanwhile I'm up past the £2,200 I need to be able to do a pension transfer, so I applied for it yesterday. I had intended to transfer it into my new AJ Bell SIPP, but their bloody useless website has no electronic transfer option. I had to print out a page, sign it and post it to them. My instant thought was "Bollocks to that!" and I did an electronic transfer from my Hargreaves Lansdown account. Afterwards I figured I was being a tad petulant, as the postage would only add a few days to the process. Next time I'll post the form.

The cash should appear in the account in around 3 weeks time, so I have to decide what to do with it. My instinct is to buy more OPTI:Optibiotix while they are so cheap, and I will do if they remain under 60p. My next instinct is to increase my SBTX:SkinBioTherapeutics holding, which I will do if they stay around 17p and OPTI go up.

However my other instinct is to get back into DDDD:4D Pharma as they have dropped back to 97p after I sold some of mine for 156p not that long ago. I would like to have some of these as I think they will be massive, but the thought of another 3 years before revenues start coming in is putting me off. They might be a good one to trade though.

The other option is to go back to my magic formula. This is a tempting option, but I do have 7 of these now in a portfolio of 12 shares. They are however nearly all in profit, so should I turn my back on them for more microbiome shares? I could be reaping regular dividends if I stick with the plan. If I go with this option, then the 2 shares I would buy are PLUS:Plus500 and PSN:Persimmon. Both of these make me nervous. I've been bitten by investing in house builders before, and if regulations tighten up on spread betting PLUS will potentially be in trouble. Having said that, regulations have tightened up and they still seem to be doing pretty well. I'd get a socking 8% dividend yield from PSN:Persimmon, and an acceptable 3% from PLUS:Plus500.

It's a difficult decision as the microbiome shares are all at a very tempting price right now. I guess I just wait until the cash arrives and see how I feel. This will be my rule:

If OPTI:Optibiotix less than 60p then buy - else
If SBTX:SkinBioTherapeutics less than 17p then buy - else
If DDDD:4D Pharma less than 100p then buy - else
Buy PLUS:Plus500 and PSN:Persimmon

Can't say fairer than that!

Week 275 Review - Back above £100K after a great week

It's great when the portfolio has a good week across the board and OPTI:Optibiotix has a tick up too, as then we get a really healthy spike up. The deficit between cost and value narrowed by £7,689 to £24,175 and combined portfolio value went back above £100K at £100,512.

There was only one big loser this week, as CMCL:Caledonia Mining dropped 7%. I'm not sure why as their results were pretty good. I suspect gold stocks have dipped as people switch back to normal equities. These are 16% down now and the worst performing of my magic formula shares.

CAML:Central Asia Metals finally announced the reinstatement of their dividend. It was reduced a tiny bit, but 6p is still 3.2% and this is only the interim dividend. It should give me £346 which is nice. The response was more muted than I hoped, but the share price is still up 5% and they are £20 from being back in profit.

IES:Invinity Energy climbed 5% after announcing a new project to supply European Marine Energy Centre (EMEC) with flow batteries for their tidal power to hydrogen project. I thought these were a goner when RED:RedT Energy gave up, but there does seem to be a flicker of hope after the merger. They are still 75% down though.

RDT:Rosslyn Data announced a new contract win and that saw them climb by 6%. They seem to have jumped on a Brexit bandwagon. The RNS describes it as a system that allows their client to "receive, manage and discharge duty suspended shipments from authorised suppliers under the Excise movement and control system (EMCS)". Hopefully there will be big demand for this post-Brexit as it's the sort of thing that could cause a major turn-around. They are still 67% down, but this was a very small investment so it's not a big dent on the portfolio.

TLOU:Tlou Energy are still climbing steadily, with another 6% rise this week. They are now just 46% down, so things are looking up. The 8,809 I bought in the open offer at 2.2p are looking great now the price is 4p.

PAY:Paypoint got hammered after news they were being investigated for competition law infringement. That seems to have been forgotten as they claw their way back. I think last week's announcement of the acquisition of Handepay and Merchant Rentals is sinking in and aiding the recovery. They climbed 7% this week and are only 4% down now.

APAX:Apax Global Alpha have been doing really well lately, and this week was no exception as they climbed 9% to go 17% up and confirm my belief in the magic formula system. I'd never even heard of them before they popped up near the top of my spreadsheet.

OPTI:Optibiotix have had a miserable few weeks, but the brakes came off and they were allowed to climb 5p. That resulted in an 8% rise and means they are only 15% down. Sometimes when the brakes come off they stay off for a week or two until we hit 67p. Then the traders start selling back down to 50p. That's been going on for years, but one day we'll break out of the cycle.

JLP:Jubilee Metals just misses out on Share of the Week for the 2nd week in a row. Their march upwards is relentless, and audited results this week showed earnings of £18.3m from revenue of £54.8m. That's before copper production comes on line. I shudder to think what next year's figures will look like, but there may be a dividend coming. This week they climbed 16% and are up by 76% and making £3,272 potential profit. I'm still glad I top-sliced 30% of my holding, although I would have made an extra £500 if I'd waited until now.

Share of the Week is ITV:ITV which gave a Q3 trading update this week. The price had risen in anticipation, and fortunately didn't fall after the event. They climbed 19% and are up by 30% in the short time I've owned them. The great thing about the magic formula system is that I'm not even slightly tempted to take the profit, as the rules state I have to hold them for 12 months. Temptation is much easier to resist when you have rules.

Back up to the £100K line which I never seem to hang onto for long.

I'm glad that was a very short stay below the trend line. lets hope we can start dragging it upwards now.

The ISA and share portfolios look like this

			Weekly Change
Cash	£9.70		+£0
Portfolio cost	£62,990.04		+£0
Portfolio sell value (bid price-commission)	£49,797.72	(-20.9%)	+£4,550.24
Potential profits	£3,272.05		+£700.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£166.63	(3.2%)	-£11.91
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£348.46	(6.6%)	-£1.27
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.0%		-0.1%
Compound performance	53%		+0%

£700 rise in potential profit thanks to JLP:Jubilee Metals and a generally healthy picture as the value climbs by £4,550.

I ought to get nervous whenever the green line reaches this point.

Back above the trend line, and it wouldn't take much more to be in the best position for a year.
The SIPP looks like this after week 259

		Weekly Change
Cash	£138.65		+£0
Portfolio cost	£58,959.20		+£0
Portfolio sell value (bid price - commission)	£48,729.45	(-17.4%)	+£3,146.30
Potential profits	£731.53		+£293.96
Yr 5 Dividends	£167.84		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£2,910.34		+£0
Yr 5 Average monthly cash profit	£246.46	(5.0%)	-£4.93
Total Dividends	£2,067.08		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£282.85	(5.8%)	-£1.10
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.9%		-0.1%
Compound performance	45%		+0%

Nice to see a small rise in potential profits as the magic formula shares creep upwards, and a socking great improvement in value mostly thanks to OPTI:Optibiotix. Rather annoyed that my 17.2p purchase of SBTX:SkinBioTherapeutics could have been made at 15.25p if I'd waited a few weeks. These are down 18% and losing £734 in just a few weeks.

There's only 1 week to go until the end of year 5. I'm certain not to be selling anything next week so it looks like I'll achieve a 5% return against portfolio cost. That's 7.8% against injection amount, so although below my 10% target it's not bad considering it's been a mad year.

Just about closer to the cost line than the injection line now. Given the cost line has gone up, I ought to be able to get above this level that I keep bouncing back down from.

This shows that we're still quite a way from the usual resistance point as the costs have increased from re-investment. Good to be back above the trend line.

The trading account looks like this after week 225

			Weekly Change
Cash	£236.18		+£0
Portfolio cost	£2,354.11		+£0
Portfolio sell value (bid price - commission)	£1,600.61	(-32.0%)	-£7.16
Potential profits	£0		+£0
Year 5 Dividends	£0		+£0
Year 5 Profit	£370.12		+£0
Yr 5 Average monthly cash profit	£94.34	(48.1%)	-£5.90
Dividends	£47.92		+£0
Profit from sales	£656.49		+£0
Average monthly cash profit	£13.57	(6.9%)	-£0.06
(Sold stocks profit + Dividends - Fees  / Months)

Very little change here, but a slight tick down in value. Still seems likely to be a long time until I can sell anything.

Staying above the injection line.

Running reasonably parallel to the trend line and fortunately still above it.

Here's my wish list:

1. TLOU:Tlou Energy announce de-watering has resumed. Not yet, but still we climb.
2. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. They are distracting us with results and things - but still no sign of these announcements.
3. OPTI:Optibiotix to get within 10% of profit. Not far to go now, as long as the seller doesn't return.
   
4. CAML:Central Asia Metals re-instate their dividend. Yes! Very happy about this and I can close this wish now.

Pay day this weekend and my pension contribution should go in towards the end of the week. It should take me over the £2,200 I need in order to transfer out £2,000 and leave £200 behind. I'll be adding the cash to my new AJ Bell account as I look to spread my risk across a few brokers. With OPTI:Optibiotix on the rise it's looking like SBTX:SkinBioTherapeutics will be my target. If that goes up before the cash arrives I'll either get back into DDDD:4D Pharma or pick out my next 2 magic formula shares.

Week 274 Review - A great week for most shares

This was a really good week across the board. The rise of £1,945 may not seem like much compared to usual, but none of it came from OPTI:Optibiotix which was flat this week. The deficit between cost and value narrowed to £31,864 and overall portfolio value increased to £92,822.

There were no shares losing 5% or more this week.

FXPO:Ferrexpo climbed 5% to go 9% up overall with potential profit of £96 along with £65 of dividends. Very happy with progress in my first magic formula share.

CMCL:Caledonia Mining has been slumping ever since I bought them, but a much appreciated 6% climb this week took them back to 9% away from breakeven. They also paid a minuscule dividend this week.

IQE:IQE have been a bit static lately, but went up 7% this week. My ISA holding is only 21% down now, so there is some hope. I only meant the ISA shares to be a short term quick win, so I'll sell them when they get back into profit and keep the ones in the SIPP longer term.

ITV:ITV had a great week climbing 10% to go 11% up with potential profit of £109. I think results are expected next week, so this will either re-rate back to pre-covid levels of 130p which would almost double my holding, or dip back down to 60p. STV:STV results were ok so here's hoping these will be the same.

TLOU:Tlou Energy had a dreadful week last week, but clawed back two thirds of those losses climbing 10%. They are still 52% down so no chance of break even for a while.

JLP:Jubilee Metals announced another deal to process copper tailings and the share price surged 14%. That takes my holding to 60% up and making £2,572 potential profit. I had a wobble about selling some, because results are either next week or the week after and there could very well be significant profit taking around then. However there are millions being traded every day, so I think there are institutional buyers and I can imagine the brokers dropping the price to try and get shares. I hope I stay strong and keep them even if there's a drop as these are too risky to try and trade.

Share of the Week is POLR:Polar Capital Holdings which climbed 16% and has gone from a loss to 15% up and £149 potential profit along with £49 dividend. These are back at their pre-covid level and would appear to be around fair value. I wouldn't complain if they stay around this value for 12 months and dish out a dividend, as I'm due to review them in June 2021 and will sell if they are no longer in my top 30 ranking.

It's a slightly pathetic looking tick up, but nice to stop the recent rot.

Not quite enough to get back above the trend line.

The ISA and share portfolios look like this

			Weekly Change
Cash	£9.70		-£3.75
Portfolio cost	£62,990.04		+£0
Portfolio sell value (bid price-commission)	£45,247.48	(-28.2%)	+£1,055.27
Potential profits	£2,572.05		+£600.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£178.54	(3.4%)	-£14.98
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£349.73	(6.7%)	-£1.34
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.1%		+0%
Compound performance	53%		+0%

Cash dropped due to ISA fee, nice boost in value, and £600 of that was a 0.6p rise in JLP:Jubilee Metals to improve potential profits by £600. Performance still above 10% target but only just.

Still way too close to the injection line

Bang on the trend line so at least it won't get dragged down again.

The SIPP looks like this after week 258

		Weekly Change
Cash	£138.65		-£11.40
Portfolio cost	£58,959.20		+£0
Portfolio sell value (bid price - commission)	£45,583.15	(-22.7%)	+£846.65
Potential profits	£437.57		+£309.64
Yr 5 Dividends	£167.84		+£5.26
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£2,910.34		+£0
Yr 5 Average monthly cash profit	£251.39	(5.1%)	-£6.14
Total Dividends	£2,067.08		+£5.26
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£283.95	(5.8%)	-£1.30
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	9.0%		+0%
Compound performance	45%		+0%

Cash went down by monthly fees, but the tiny £5 dividend from CMCL:Caledonia Mining helped reduce that drop. Potential profits up a healthy £309 thanks to the magic formula shares, and there was an additional £500 of reduced losses. Just 2 weeks to go in year 5 so it looks like I'll only achieve performance of 5% of current portfolio cost, but that's pretty good considering the dreadful year we've had and the fact most shares still haven't recovered from the covid losses.

Still nearer injection than cost, but a healthy buffer.

Quite a bit below the trend line, so need to resolve that quick else it won't be pointing up for long.

The trading account looks like this after week 224

			Weekly Change
Cash	£236.18		+£0
Portfolio cost	£2,354.11		+£0
Portfolio sell value (bid price - commission)	£1,607.77	(-31.7%)	+£43.36
Potential profits	£0		+£0
Year 5 Dividends	£0		+£0
Year 5 Profit	£370.12		+£0
Yr 5 Average monthly cash profit	£100.24	(51.1%)	-£6.68
Dividends	£47.92		+£0
Profit from sales	£656.49		+£0
Average monthly cash profit	£13.63	(6.9%)	-£0.06
(Sold stocks profit + Dividends - Fees  / Months)

Not a bad week, although not enough to make up for last week's losses. Most shares ticked up except SBTX:SkinBioTherapeutics which is increasingly appearing to be a very badly timed investment.

Back above the injection line, which for a long time I never expected to ever happen.

Nicely above the trend line, so all under control here.

Here's the wish list:

1. TLOU:Tlou Energy announce de-watering has resumed. Nope, but the price continues to climb so I don't care.
2. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. Still no news of this, just the new copper deal which wasn't expected. If these two are announced as well then we'll be rocking.
3. OPTI:Optibiotix to get within 10% of profit. No news all week and the share price stayed still. That's a good thing as it suggests the seller is pausing for breath, but nobody is buying. If there is news next week then maybe this wish will come true.
   
4. CAML:Central Asia Metals re-instate their dividend. It's getting close. They gave an update on the pollution clean up and made it clear the dividend will be re-instated soon. I suspect they're just letting the cleanup progress a bit further before being seen to dish out money to shareholders.

Good solid week. Lets hope all the messing around in USA gets cleared up soon and we have another up week next week.